期刊文献+

各期慢性阻塞性肺疾病患者诱导痰细胞成分与肺功能的关系 被引量:26

Relationship between Lung Function and Induced Sputum Cell Characteristics in Patients with Chronic Obstructive Pulmonary Disease in Different Stages
下载PDF
导出
摘要 【目的】比较不同时期慢性阻塞性肺病(COPD)患者诱导痰中细胞组成的变化,及其诱导痰中细胞成分尤其中性粒细胞百分比与气流受限的关系。【方法】对110例COPD患者[急性加重期COPD(AECOPD)患者(A1组)62例、稳定期COPD患者(B组)48例]及30例健康对照者(C组)进行肺功能测定及痰诱导,痰液处理后沉渣作细胞学分析。其中AECOPD组在治疗1周后(A2组)再次进行上述指标的测定。【结果】140例受试者中有21例因不能耐受痰诱导过程或痰标本不合格而退出研究,最终有119例受试者完成本研究(A1,2组48例,B组43例,C组28例)。A1组、A2组、B组、C组诱导痰中细胞总数(106/mL)分别为(8.8±3.7)、(6.5±2.6)、(5.0±2.8)、(2.8±1.3),细胞分类中A1组、A2组、B组以中性粒细胞为主,分别为66%±15%、60%±10%、55%±11%,而在C组中则以巨噬细胞、中性粒细胞为主,分别为37%±10%、32%±8%;AECOPD患者(A1组、A2组)诱导痰中性粒细胞百分比与肺功能指标(FEV1、FEV1%pre、FVC、FEV1/FVC)呈负相关(r分别为-0.860、-0.682、-0.662、-0.300,P<0.001);稳定期组(B组)中性粒细胞与FEV1、FEV1%pre负相关(r分别为-0.346、-0.421,P<0.05),对照组中性粒细胞与肺功能无相关性(P>0.05)。【结论】AECOPD、缓解期、稳定期患者诱导痰细胞以中性粒细胞为主,健康者诱导痰细胞以巨噬细胞为主;气道局部中性粒细胞增多与各期COPD患者气流受限存在密切的关系。 [Objective] To compare the induced sputum characteristics of COPD (chronic obstructive pulmonary disease) patients in different stages with that of normal subjects, and eximine the relationship between the airflow limitation and the induced sputum characteristics especially the number of sputum neutrophils of COPD patients. [Methods] Sputum induction and the lung function were performed in 110 COPD patients (62 acute exacerbation of COPD(AECOPD)(Group A1), 48 stable COPD patients (Group B), and 30 healthy volunteers (Group C). And the same measurements were repeated in the patients with AECOPD after a short-term (1 week ) treatment. We called them catabatic AECOPD patients (group A2). Cell components of induced sputum of the 4 groups were analyzed. [ Results ] Of the 140 subjects enrolled, 119 finally finished the study (48 in group A1, 43 in group B, and 28 in group C). Total cell counts(10 6/ml )in group Al, group A2, and group B were (8.8 ± 3.7),(6.5 ± 2.6),(5.0 ± 2.8), and (2.8 ±1.3), respectively. The main cell differential (%) of group A1, group A2, and group B were neutrophils:66% ± 15%,60% ± 10%, and 55% ± 11%, respectively. While in group C, the main cell differentials (%) were macrophages and neutrophils, and their percentage were 37% ± 10% and 32% ± 8%, respectively. The percentage of neutrophils was negatively correlated with lung function (FEV1, FEV1%pre, FVC, FEV1/FVC )in the patients with AECOPD groups(group A1, A2)(r= -0.860, -0.682, -0.662, and -0.300, respectively,P〈 0.001 ). And the percentage of neutrophils in group B was also negatively correlated with FEV1 and FEV1%pre (r was -0.346 and -0.421, respectively, P〈 0.05),while there was no relationship between neutrohpils and lung function in group C (P 〉 0.05). [Conclusions] The main cell differential in induced sputum was neutrophils in the patients with acute exacerbation COPD, catabatic AECOPD and stable COPD, while in healthy volunteers were macrophages.The increased number of neutrophils in the local airway was closely related to the airflow limitation in COPD patients.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2007年第4期422-425,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省自然科学基金项目(04009385) 广东省卫生厅基金项目(A2004188)
关键词 阻塞性肺疾病 诱导痰 中性粒细胞 obstructive pulmonary disease induced sputum neutrophils
  • 相关文献

参考文献10

  • 1FABBRI L M,HURD S S,GOLD SCIENTIFIC COMMITTEE.Global strategy for the diagnosis,management,and prevention of COPD 2003 update[J].Eur Resp J,2003,22(1):1-2.
  • 2曾勉,吴健锋,谢灿茂,严英硕,陈冬梅,禤建美.慢性阻塞性肺疾病急性加重期患者规范化痰诱导安全性的初步研究[J].中华结核和呼吸杂志,2005,28(4):238-241. 被引量:45
  • 3SUTHERLAND E R,PAK J,Langmack E L,et al.Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease[J].Respir Med,2002,96(7):482-486.
  • 4CELLI B R,MACNEE W,ATS/ERS TASK FORCE.Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper[J].Eur Respir J,2004,23(6):932-946.
  • 5KIPS J C,INMAN M D,JAYARAM L,et al.The use of induced sputum in clinical trials[J].Eur Respir J,2002,37(Suppl):47s-50s.
  • 6KRISIUKENIENE A,SITKAUSKIENE B,MALAKAUSKAS K.Peculiarities of induced sputum inflammatory cell counts in allergic versus non-allergic asthma[J].Medicina (Kaunas),2005,41(3):196-202.
  • 7DOMAGALA K J,MASKEY W M,KRASZEWSKA I.The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD[J].Chest,2003,123(4):1054-1059.
  • 8BALZANO G,STEFANELLI F,IORIO C,et al.Eosinophilic Inflammation in Stable Chronic Obstructive Pulmonary Disease:Relationship with Neutrophils and Airway Function[J].Am J Respir Crit Care Med,1999,160(5):1486-1492.
  • 9O'DONNELL R A,PEEBLES C,WARD J A,et al.Relationship between peripheral airway dysfunction,airway obstruction,and neutrophilic inflammation in COPD[J].Thorax,2004,59(7):837-842.
  • 10SAETTA M,DI STENFANO A,MAESTRELLI P,et al.Airway eosinophilia in chronic bronchitis during exacerbations[J].Am J Respir Crit Care Med,1994,150(6):1646-1652.

二级参考文献12

  • 1Pin I,Gibson PG,Kolendowicz R,et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax,1992,47:25-29.
  • 2Sutherland ER,Pak J,Langmack EL,et al. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med,2002,96:482-486.
  • 3Fabbri LM,Hurd SS,GOLD Scientific Committee. Global strategy for the diagnosis,management and prevention of COPD:2003 update. Eur Respir J,2003,22:1-2.
  • 4Celli BR,MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper. Eur Respir J,2004,23:932-946.
  • 5Bach PB,Brown C,Gelfand SE,et al. Management of acute exacerbations of chronic obstructive pulmonary disease:a summary and appraisal of published evidence. Ann Intern Med,2001,134:600-620.
  • 6Vignola AM,Rennar SI,Hargreave FE,et al. Standardised methodology of sputum induction and processing. Future directions. Eur Respir J Suppl,2002,37:51s-55s.
  • 7Tsoumakidou M,Tzanakis N,Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir Med,2003,97:863-871.
  • 8Vlachos-Mayer H,Leigh R,Sharon RF,et al. Success and safety of sputum induction in the clinical setting. Eur Respir J,2000,16:997-1000.
  • 9Rohde G,Wiethege A,Borg I,et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation:a case-control study. Thorax,2003,58:37-42.
  • 10Leigh R,Sharon RF,Efthimiadis A,et al. Diagnosis of left-ventricular dysfunction from induced sputum examination. Lancet,1999,354:833-834.

共引文献44

同被引文献203

引证文献26

二级引证文献217

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部